Patients who receive avacopan for antineutrophil cytoplasmic antibody-associated vasculitis demonstrate fewer infections and ...

Adenosine deaminase 2 (ADA2) plays a critical role in immune regulation, particularly in monocyte differentiation and ...

A woman in her 40s with a history of a subarachnoid haemorrhage complicated by ischaemic infarcts presented with 1 week of ...

Disney rash, medically known as exercise-induced vasculitis (EIV), often affects visitors to theme parks after prolonged ...

The immunoglobulin A IgA vasculitis market size has shown solid growth in recent years, escalating from $1.53 billion in 2024 to $1.63 billion in 2025, indicating a compound annual growth rate CAGR of ...

Dr. Kimberly Trotter distilled four high-impact disease clusters—gout, rheumatoid arthritis (RA), systemic lupus ...

RA primarily affects the joints, but it can also cause symptoms in other areas of the body, such as the skin. Learn how RA ...

Here's a new summary of all the drugs in the pipeline currently being evaluated for the treatments of vasculitis.

Distinct patterns on chest computed tomography (CT) scans among patients with interstitial lung disease (ILD) and antineutrophil cytoplasmic antibody-associated vasculitis (AAV) are linked to varied ...

A common medication already used for autoimmune diseases such as rheumatoid arthritis is effective for patients with giant ...

Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Regeneron Pharmaceuticals is spearheading a study titled ...

Vasculitis, a severe blood vessel condition, drives the global market's growth due to advancements in biologic treatments like monoclonal antibodies. Enhanced diagnostics and personalized medicine ...